Lonafarnib
Zokinvy (lonafarnib) is a prescription oral capsule medication that acts as a farnesyltransferase inhibitor. It comes in 50mg and 75mg strengths and is manufactured by Sentynl Therapeutics, Inc. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Zokinvy (lonafarnib) is a prescription oral capsule medication that acts as a farnesyltransferase inhibitor. It comes in 50mg and 75mg strengths and is manufactured by Sentynl Therapeutics, Inc. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Lonafarnib",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Lonafarnib — ANDA 213969 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213969"
}
]
|
| identifier | ANDA213969 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-safety",
"health-care",
"medications",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Lonafarnib |
